Canada Life’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-48,524
Closed -$2.47M 2029
2024
Q4
$2.47M Sell
48,524
-12,153
-20% -$597K ﹤0.01% 1170
2024
Q3
$2.5M Sell
60,677
-3,131
-5% -$150K ﹤0.01% 1204
2024
Q2
$3.07M Buy
63,808
+10,521
+20% +$466K 0.01% 1073
2024
Q1
$2.55M Buy
53,287
+24,562
+86% +$1.31M 0.01% 1126
2023
Q4
$1.86M Buy
28,725
+522
+2% +$31.4K ﹤0.01% 1281
2023
Q3
$1.84M Buy
28,203
+13
+0% +$818 ﹤0.01% 1258
2023
Q2
$1.64M Sell
28,190
-3,841
-12% -$242K ﹤0.01% 1299
2023
Q1
$1.98M Hold
32,031
﹤0.01% 1233
2022
Q4
$2.04M Buy
32,031
+2,969
+10% +$215K 0.01% 1229
2022
Q3
$2.11M Buy
29,062
+7,882
+37% +$587K 0.01% 1143
2022
Q2
$1.44M Buy
21,180
+20,047
+1,769% +$1.44M ﹤0.01% 1312
2022
Q1
$109K Hold
1,133
﹤0.01% 1977
2021
Q4
$103K Hold
1,133
﹤0.01% 2004
2021
Q3
$92K Hold
1,133
﹤0.01% 2073
2021
Q2
$106K Hold
1,133
﹤0.01% 2078
2021
Q1
$120K Buy
1,133
+452
+66% +$46.9K ﹤0.01% 2058
2020
Q4
$59K Buy
+681
New +$48.1K ﹤0.01% 2226

Other funds holding NARI

Canada Life's NARI Position: Q1 2025 in Review

Canada Life sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 48,524 shares — an estimated $2.47M sold.

Canada Life first reported a position in NARI in Q4 2020 and held it in 17 quarters. The position peaked at $3.07M in Q2 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Canada Life reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Canada Life sold 48,524 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $2.47M.
  • Canada Life first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 17 quarters.
  • Canada Life's Inari Medical, Inc. Common Stock position peaked at $3.07M in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Canada Life's 13F filing for Q1 2025, filed 15 May 2025.